198 related articles for article (PubMed ID: 20456926)
21. Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole.
Müller J; Ley S; Felger I; Hemphill A; Müller N
J Antimicrob Chemother; 2008 Jul; 62(1):72-82. PubMed ID: 18408240
[TBL] [Abstract][Full Text] [Related]
22. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance.
Leitsch D; Kolarich D; Binder M; Stadlmann J; Altmann F; Duchêne M
Mol Microbiol; 2009 Apr; 72(2):518-36. PubMed ID: 19415801
[TBL] [Abstract][Full Text] [Related]
23. Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Reyes-Vivas H; de la Mora-de la Mora I; Castillo-Villanueva A; Yépez-Mulia L; Hernández-Alcántara G; Figueroa-Salazar R; García-Torres I; Gómez-Manzo S; Méndez ST; Vanoye-Carlo A; Marcial-Quino J; Torres-Arroyo A; Oria-Hernández J; Gutiérrez-Castrellón P; Enríquez-Flores S; López-Velázquez G
Antimicrob Agents Chemother; 2014 Dec; 58(12):7072-82. PubMed ID: 25223993
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin.
Sterk M; Müller J; Hemphill A; Müller N
Microbiology (Reading); 2007 Dec; 153(Pt 12):4150-4158. PubMed ID: 18048928
[TBL] [Abstract][Full Text] [Related]
25. Metronidazole and Secnidazole Carbamates: Synthesis, Antiprotozoal Activity, and Molecular Dynamics Studies.
Rocha-Garduño G; Hernández-Martínez NA; Colín-Lozano B; Estrada-Soto S; Hernández-Núñez E; Prieto-Martínez FD; Medina-Franco JL; Chale-Dzul JB; Moo-Puc R; Navarrete-Vázquez G
Molecules; 2020 Feb; 25(4):. PubMed ID: 32059495
[TBL] [Abstract][Full Text] [Related]
26. Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole.
Cruz A; Sousa MI; Azeredo Z; Leite E; Figueiredo de Sousa JC; Cabral M
J Antimicrob Chemother; 2003 Apr; 51(4):1017-20. PubMed ID: 12654760
[TBL] [Abstract][Full Text] [Related]
27. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
Lemée V; Zaharia I; Nevez G; Rabodonirina M; Brasseur P; Ballet JJ; Favennec L
J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram.
Galkin A; Kulakova L; Lim K; Chen CZ; Zheng W; Turko IV; Herzberg O
J Biol Chem; 2014 Apr; 289(15):10502-10509. PubMed ID: 24558036
[TBL] [Abstract][Full Text] [Related]
29. The effects of the antiprotozoal drugs metronidazole and furazolidone on trophozoites of Giardia lamblia (P1 strain).
Campanati L; Monteiro-Leal LH
Parasitol Res; 2002 Jan; 88(1):80-5. PubMed ID: 11822742
[TBL] [Abstract][Full Text] [Related]
30. Effect of metronidazole analogues on Giardia lamblia cultures.
Busatti HG; Vieira AE; Viana JC; Silva HE; Souza-Fagundes EM; Martins-Filho OA; Alves RJ; Gomes MA
Parasitol Res; 2007 Dec; 102(1):145-9. PubMed ID: 17906962
[TBL] [Abstract][Full Text] [Related]
31. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
Nabarro LE; Lever RA; Armstrong M; Chiodini PL
Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
[TBL] [Abstract][Full Text] [Related]
32. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
Carter ER; Nabarro LE; Hedley L; Chiodini PL
Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
[TBL] [Abstract][Full Text] [Related]
33. The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
Dunn LA; Andrews KT; McCarthy JS; Wright JM; Skinner-Adams TS; Upcroft P; Upcroft JA
Int J Antimicrob Agents; 2007 Jan; 29(1):98-102. PubMed ID: 17137752
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel antigiardiasis drug candidates.
Kulakova L; Galkin A; Chen CZ; Southall N; Marugan JJ; Zheng W; Herzberg O
Antimicrob Agents Chemother; 2014 Dec; 58(12):7303-11. PubMed ID: 25267663
[TBL] [Abstract][Full Text] [Related]
35. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.
Tejman-Yarden N; Miyamoto Y; Leitsch D; Santini J; Debnath A; Gut J; McKerrow JH; Reed SL; Eckmann L
Antimicrob Agents Chemother; 2013 May; 57(5):2029-35. PubMed ID: 23403423
[TBL] [Abstract][Full Text] [Related]
36. Ferredoxin involvement in metronidazole resistance of Giardia duodenalis.
Liu SM; Brown DM; O'Donoghue P; Upcroft P; Upcroft JA
Mol Biochem Parasitol; 2000 Apr; 108(1):137-40. PubMed ID: 10802327
[No Abstract] [Full Text] [Related]
37. Physiological aspects of nitro drug resistance in Giardia lamblia.
Müller J; Hemphill A; Müller N
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):271-277. PubMed ID: 29738984
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
Adagu IS; Nolder D; Warhurst DC; Rossignol JF
J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
Abboud P; Lemée V; Gargala G; Brasseur P; Ballet JJ; Borsa-Lebas F; Caron F; Favennec L
Clin Infect Dis; 2001 Jun; 32(12):1792-4. PubMed ID: 11360222
[TBL] [Abstract][Full Text] [Related]
40. Giardiasis: a pharmacotherapy review.
Escobedo AA; Cimerman S
Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
